CN104987377B - Natural anti-infective antitumor bifunctional polypeptides ECCT and its gene and application - Google Patents
Natural anti-infective antitumor bifunctional polypeptides ECCT and its gene and application Download PDFInfo
- Publication number
- CN104987377B CN104987377B CN201510341844.7A CN201510341844A CN104987377B CN 104987377 B CN104987377 B CN 104987377B CN 201510341844 A CN201510341844 A CN 201510341844A CN 104987377 B CN104987377 B CN 104987377B
- Authority
- CN
- China
- Prior art keywords
- ecct
- antitumor
- application
- infective
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a kind of natural anti-infective antitumor bifunctional polypeptides ECCT and its encoding gene and application, ECCT is made up of 30 amino acid residues, for straight-chain polypeptide, molecular weight 3662.7Da, isoelectric point 12.33, the encoding gene of ECCT precursors is straight chain nucleotide sequence of the length for 720 bases, and polypeptide ECCT has the beneficial features such as molecular weight is small, chemical synthesis process is simple, strong, the antitumor activity broad-spectrum high efficacy of antibacterial action broad-spectrum high efficacy, anti-inflammatory activity, is with a wide range of applications.
Description
Technical field
The invention belongs to field of biomedicine technology, specifically a kind of natural anti-infective antitumor bifunctional polypeptides
ECCT and its gene and application.
Background technology
Microorganism infection can cause serious locally or systemically diseases associated with inflammation, such as pneumonia, gastritis, peritonitis and pyemia
Deng the extensive abuse of conventional antibiotic causes increasingly severe pathogenic microorganism resistance problems in recent years, to human health
Bring huge threat.The measure for clinically tackling drug-resistant microorganism infection is to use new or alternative antibiotic, because
This this just need the new anti-microbial infection medicine of Persisting exploitation.
Tumour is body under the effect of various carcinogenic factors, and the cell of local organization loses on gene level to be grown to it
Normal regulation, the neoformation for causing its clonal abnormality hyperplasia and being formed.Tumour is generally divided into benign and malignant two major class, its
Middle malignant tumour is the high a kind of disease of the death rate, and its fatal rate is in second in all diseases of the mankind.Malignant tumour
Treatment method, mainly have three kinds of operation, radiotherapy and chemotherapy at present, but operative treatment is only applicable to early stage entity
Knurl, radiotherapy side effect is big, and chemotherapy one side side effect is big, and another aspect tumour easily produces drug resistance.Therefore
Need to develop more tumor therapeuticing methods, including the research and development of new type antineoplastic medicine.
Polypeptide is a kind of macromolecular substances being formed by connecting by different aminoacids residue by amido link condensation, at present from
The largely peptide molecule with different structure and function is found in the various organisms of nature, these peptide molecules show various
Biological activity, such as antibacterial, anti-inflammatory, immunological regulation, it is antitumor and promote wound reparation.
Antibacterial peptide is a kind of natural small molecule polypeptide of organism gene code, is a kind of important of organism immune system
Molecule, direct killing action is respectively provided with to bacterium, fungi, virus even protozoon.In addition, some antibacterial peptides also have suppression
Inflammatory factor secretion processed, adjusts the effect of immune response.
Natineoplaston is a kind of polypeptide for having and suppressing tumor cell proliferation or killing activity of tumor cells, never at present
With finding tens of kinds of natineoplastons in organism.The natineoplaston mechanism of action is various, such as induced tumor membranolysis, induction
ROS generations, induced tumor meronecrosis and apoptosis etc..Polypeptide generally have molecular weight is small, simple in construction, pharmacological activity is strong,
The advantages that mechanism of action is various, toxicity is low and is not easy to cause drug resistance, there is great potentiality to be exploited in new drug development field.
The content of the invention
It is an object of the invention to provide a kind of natural anti-infective antitumor bifunctional polypeptides ECCT and its gene and application.
To achieve the above object, the technical solution adopted by the present invention is:
One of the object of the invention is to provide a kind of polypeptide ECCT, the straight-chain polypeptide being made up of 30 amino acid residues, molecule
Amount 3662.7Da, isoelectric point 12.33, the primary structure of its amino acid sequence are O.1 shown by SEQ ID N:
Ser1Arg2Lys3Leu4Lys5Lys6Phe7Phe8Arg9Lys10Val11Lys12Lys13Gly14Il
e15Lys16Lys17Val18Phe19Lys20Lys21Val22Val23Lys24Ala25Ile26Phe27Arg28Leu29Leu30。
The two of the object of the invention are to provide a kind of gene of polypeptide ECCT precursors, are made up of 720 nucleotides, from 5 ' ends extremely
The base sequence at 3 ' ends is as shown in SEQ ID NO.2:
The three of the object of the invention are to provide a kind of polypeptide ECCT preparation method, and this method is carried out successively according to the following steps:
1) total serum IgE of derived tissues is extracted;
2) construction cDNA library;
3) synthetic pcr primer thing is designed, enters performing PCR amplification ECCT coding gene sequences.
4) ECCT coding gene sequences are expanded according to PCR and derives ripe peptide amino acid sequence;
5) with automatic Peptide synthesizer synthesis polypeptide ECCT complete sequences;
6) HPLC reversed phase column chromatography desalinations are passed through.
Polypeptide ECCT of the present invention can be used for preparing antibacterials, anti-inflammatory drug, antineoplastic, suppression bacterium life
Long medicine, preservative, animal feed or cosmetic additive agent.
Polypeptide ECCT of the present invention base sequence can be applied to polypeptide recombination expression, transgenic animals, plant, plant
In thing part, zooblast or plant cell.
The present invention is detected by experiment to ECCT antibacterial activities, sterilization speed, anti-inflammatory activity and antitumor activity, institute
Stating polypeptide ECCT has that molecular weight is small, chemical synthesis process is simple, antibacterial action broad-spectrum high efficacy, anti-inflammatory activity are strong, antitumor work
The beneficial features such as property broad-spectrum high efficacy, are with a wide range of applications.
Described above is only the general introduction of technical solution of the present invention, in order to better understand the technological means of the present invention,
And can be practiced according to the content of specification, below with presently preferred embodiments of the present invention and coordinate accompanying drawing describe in detail as after.
Brief description of the drawings
Fig. 1 is that ECCT suppresses the TNF-α that LPS is induced in Turnover of Mouse Peritoneal Macrophages, IL-1 β, IL-6 and iNOS genes turn
Record.**P<0.01.
Embodiment
With reference to the accompanying drawings and examples, the embodiment of the present invention is described in further detail.Implement below
Example is used to illustrate the present invention, but is not limited to the scope of the present invention.
Embodiment 1
The clone of natural anti-infective antitumor bifunctional peptide ECCT encoding genes:
1) water snake (Enhydris chinensis) lung Total RNAs extraction:
1. taking 250mg water snake lung tissues, it is put into mortar and adds liquid nitrogen grinding into powder, be transferred in EP pipes, add
Enter 1m1 total RNA extraction reagents (Trizol, U.S.'s Invitrogen Products), fully mix, and after 4 DEG C, 12000rpm
Centrifuge 10min.
2. centrifuging and taking supernatant, adding 0.2ml chloroformic solutions, acutely mixing, room temperature is placed 10 minutes, then with 4 DEG C,
12000rpm is centrifuged 10 minutes, reject precipitation.
3. supernatant adds isometric isopropanol, room temperature is placed 10 minutes, and with 4 DEG C, 12000rpm is centrifuged 10 minutes, is collected
Precipitation is washed once with 75% (V/V) ethanol, is dried, ttom of pipe sediment is water snake lung total serum IgE.
2) water snake lung cDNA library is built:Using CLONTECH companies SMARTTM cDNA Library
Construction Kit are built.
(1) chains of cDNA first synthesis (mRNA reverse transcriptions):
1. through DEPC processing (DEPC processing is in the water soaked overnight containing 0.1% (V/V) DEPC, autoclaving, drying)
Centrifuge tube in add 3 μ l water snake lungs total serum IgEs, 1 μ l SMART IV Oligonucleotide and 1 μ l CDS III/3 '
PCR Primer, of short duration centrifugation (2000rpm, 30s), centrifuges and is incubated 2 minutes after 72 DEG C after mixing;Then by centrifuge tube in ice
It is upper to place 2 minutes.
2. following reagent (being to build in the kit of storehouse to be equipped with), 2.0 5 × First- of μ l are added in above-mentioned centrifuge tube
strand Buffer、1μl 20mM DTT、1.0μl 10mM dNTP Mix、1.0μl SMARTScribe MMLV Reverse
Transcriptase, reagent and of short duration centrifugation (2000rpm, 30s) in centrifuge tube are mixed, 60min is incubated at 42 DEG C, will centrifuge
Pipe is placed in the synthesis for stopping the first chain on ice.Take the chains of cDNA first synthesized by 2 μ l standby from centrifuge tube.
(2) using the second chain of long end polymeric PCR (LD-PCR) method amplification, (agents useful for same is to build storehouse examination
It is equipped with agent box)
1. by 2 μ l First-strand cDNA, 80 μ l Deionized H2O、10μl 10×Advantage2PCR
Buffer, 2 μ l 50 × dNTP Mix, PCR Primer of 2 μ l 5 ', 2 μ l CDS III/3 ' PCR Primer and 2 μ l 50 ×
Mixed in the PCR pipe of Advantage 2Polymerase Mix preheatings at 95 DEG C.
2. expanded in PCR instrument by following procedure:95 DEG C, 1min;18 circulations:95 DEG C, 15sec, 68 DEG C, 6min.Follow
After ring terminates, -80 DEG C of the cDNA double-strands that will be synthesized in centrifuge tube preserve.
(3) ECCT encoding genes are cloned:
Engineer synthesizes forward primer and enters performing PCR amplification, and its sequence is 5'-ATGGAGGGCTGTTTCTGGAAGACC-
3'(SEQ ID NO:3), another amplimers of PCR are the 3 '-PCR primer built in the kit of storehouse, its sequence is 5 '-
CTAGAGGCCGAGGCGGCCGACATG-3’(SEQ ID NO:4).PCR reactions are carried out under the following conditions:94 DEG C of 5min, 94
DEG C 30sec, 58 DEG C of 30sec and 72 DEG C of 1min, 30 circulations.After the completion of amplification mesh is carried out with glue reclaim kit (Tiangeng biology)
Fragment recovery.The purpose fragment of recovery is connected to pMD19-T carriers (Takara, Dalian), is transformed into CaCl2-MgCl2Method
The DH5 α competent cells prepared.Coated plate simultaneously carries out ampicillin and blue hickie Double Selection, and picking single bacterium colony is drawn with M13
Thing PCR detects Insert Fragment size.Picking positive bacterium colony, bacterium extraction plasmid is shaken, uses Applied Biosystems DNA
Sequencer, model ABI PRISM 377 carry out nucleotide sequencing.
Measurement result:
The gene of coding ECCT precursors shown in SEQ ID NO.2 is held to 3 ' terminal sequences from 5 ':
It is 469-558 positions nucleotides wherein to encode ECCT.
The encoding gene nucleotides sequence list of ECCT precursors is:Sequence length is 720 bases, sequence type:Nucleic acid, chain
Number:It is single-stranded, topology:Straight-chain, sequence species:CDNA, source:Water snake lung.
Embodiment 2
ECCT chemical synthesis:
Ith, ECCT chemical synthesis process:The ripe peptide amino acid sequence derived according to gene, with automatic Peptide synthesizer
(433A, Applied Biosystems) synthesizes its complete sequence, passes through HPLC reversed phase column chromatography desalinations.
IIth, molecular weight determination uses MALDI-TOF-MS (MALDI-TOF).
IIIth, the ECCT of purifying identifies its purity with high-efficient liquid phase chromatogram HPLC method, and molecular weight determination uses Matrix-assisted
MALDI-TOF-MS (MALDI-TOF), isoelectric focusing electrophoresis measure isoelectric point, with automatic Protein Sequencer
Determine amino acid sequence structure.
ECCT is a kind of straight-chain polypeptide of ECCT gene codes, containing 30 amino acid residues, molecular weight 3662.7Da, etc.
Electricity point 12.33, its SEQ ID NO.1 amino acid sequence are:
Ser1Arg2Lys3Leu4Lys5Lys6Phe7Phe8Arg9Lys10Val11Lys12Lys13Gly14Ile15Lys16Lys17Val18Phe19L
ys20Lys21Val22Val23Lys24Ala25Ile26Phe27Arg28Leu29Leu30。
Embodiment 3
ECCT antibacterial activities detect:
(1) test strain that picking is stored on inclined-plane respectively is spread evenly across MH solid mediums and (is purchased from Qingdao Hai Bo
Bioisystech Co., Ltd) on flat board, the filter paper of the 0.5cm diameters by sterilizing is placed in media surface, dissolving is added dropwise
In the 2mg/ml of the sterile deionized water μ l of ECCT sample solutions 10, culture 18-20 hours are inverted in 37 DEG C, observe inhibition zone
Whether formed.If sample has antibacterial activity, Clear & Transparent inhibition zone, the bigger table of inhibition zone can be formed around filter paper
Bright sample antibacterial activity is stronger.
(2) ECCT minimal inhibitory concentrations (Minimum Inhibitory Concentration) measure (2 times of dilution methods):
The bacterial strain for having inhibition zone in step experiment in selection carries out MIC determination experiments.Test strain is inoculated into the training of MH liquid
Support in base (Qingdao Hai Bo Bioisystech Co., Ltd), 37 DEG C of shaken cultivations to exponential phase, then trained with fresh MH liquid
Support base and culture to the nutrient solution of exponential phase is diluted to 2 × 105Cfu/ml is stand-by.
100 μ l MH fluid nutrient mediums are previously added in sterile each hole of 96 orifice plate, 100 μ l are then added in the first hole
The certain density ECCT sample solutions through 0.22 μm of hole membrane filtration are diluted to MH fluid nutrient mediums, 100 μ are taken after mixing
L adds the 2nd hole, successively doubling dilution (referring to table 1), and suctioning out 100 μ l from the 9th hole discards, the 10th hole system control tube.
Table .1 dilution process
37 DEG C of placement slowly vibrating culture 18 hours, determines light absorbs at 600nm wavelength after above-mentioned each pipe is mixed.Most
Small Mlc is the minimum sample concentration of invisible bacterial growth.As a result it is as shown in table 2.
From table 2, ECCT is to going out very strong antibacterial activity, and including largely pathogenic bacteria are clinically separated, MIC value is in
1.17-37.5 μ g/ml scope.
The ECCT antibacterial activities of table 2
MIC:Minimal inhibitory concentration, result above repeat laboratory mean values to be independent three times.
Embodiment 4
ECCT sterilization speeds determine
Escherichia coli ATCC25922 cultivates 12 with MH fluid nutrient mediums (Qingdao Hai Bo Bioisystech Co., Ltd) at 37 DEG C
Hour, then it is diluted to 10 with fresh MH fluid nutrient mediums6CFU/ml bacteria suspension.It will be dissolved in the deionized water of sterilizing
ECCT samples be added in bacteria suspension, make final concentration of 5 × MIC (93.75 μ g/ml).The bacterium solution for adding ECCT samples is put
Concussion and cultivate in 37 DEG C of incubators is placed in, took 50 μ l bacterium solutions to dilute at 0,5,10,20,30,45,60,90 and 120 minute respectively
1000 times, the bacterium solution for then taking 50 μ l to dilute is applied on MH solid mediums, and bacterium colony counts after 37 DEG C of incubator overnight incubations.
The experiment is by the use of Meropenem as positive control, and the deionized water of sterilizing is as negative control.
As a result as shown in table 3, ECCT bactericidal actions are rapid, and all Escherichia coli can be killed in 10 minutes
ATCC25922 cells.And positive control Meropenem needs 120 minutes could kill all bacterial cells.Illustrate killing for ECCT
Bacterium speed is faster than conventional antibiotic.
The ECCT sterilization speeds of table 3
Embodiment 5
ECCT anti-inflammatory activities determine
Brewer thioglycollate medium (Sigma-Aldrich, USA) is expelled in C57 mouse peritoneals, is located after 3 days
Dead mouse, collect Turnover of Mouse Peritoneal Macrophages.The Turnover of Mouse Peritoneal Macrophages of collection (contains 10% tire with RPMI-1640 nutrient solutions
Cow's serum, 100U/ml penicillin, 100 μ g/ml streptomysins) culture, plate is planted after cell count, is made in 96 orifice plates per hole cell number
For 1 × 104It is individual.After cell attachment, upper cell nutrient solution is sucked, fresh RPMI-1640 nutrient solutions is added and (contains 10% tire ox blood
Clearly, 100U/ml penicillin, 100 μ g/ml streptomysins).Add ECCT samples (various concentrations gradient) and Helicobacter pylori lipopolysaccharide
LPS (final concentration of 100ng/ml), cell culture incubator culture 6h, is collected by centrifugation cell, using Trizol reagents (Life tech,
The U.S.) extraction cell total rna, utilize Takara PrimeSript 1st Strand cDNA Synthesis Kit
(Takara, Japan) Reverse Transcriptase kit reverse transcription synthesis chains of cDNA mono-, utilize SYBR Premix Ex TaqTM II(Tli
RNaseH Plus) two-step qRT-PCR Kit (Takara, Japan) carry out qRT-PCR experiment detection ECCT samples to deep and remote
The influence of the proinflammatory factor gene expression of Helicobacter pylori LPS inductions.
As a result as shown in figure 1, ECCT can significantly inhibit what helicobacter pylori LPS in Turnover of Mouse Peritoneal Macrophages was induced
INOS genes and proinflammatory factor IL-1 β, IL-6, TNF-α gene transcription, show that ECCT has stronger anti-inflammatory activity.
Embodiment 6
ECCT antitumor cytolytic activities
With mtt assay detection ECCT samples anti tumor activity in vitro, experiment with tumor cell line include prostate cancer PC3,
Liver cancer HepG2, colon cancer Colon38 and stomach cancer BGC823.Cell (contains 10% hyclone, 100U/ with the high sugared nutrient solutions of DMEM
Ml penicillin, 100 μ g/ml streptomysins) culture, after cell covers with, with 0.25% Trypsin Induced, 2 are washed with nutrient solution
Secondary, suspension cell, plate is planted after cell count again, and it is 1 × 10 to make every hole cell number in 96 orifice plates5It is individual, per the μ l of pore volume 200.
Cell culture incubator culture 3h, adds the ECCT samples of various concentrations gradient after cell attachment, and blank control group adds same volume
Long-pending sterile deionized water, continue in cell culture incubator to cultivate 48h.20 μ l MTT solution of every hole addition (5mg/ml, it is molten with PBS
Solution), continue to cultivate 4h.Culture is terminated, carefully sucks nutrient solution in hole.150 μ l dimethyl sulfoxide (DMSO)s are added in per hole, liquid-transfering gun blows
Beating is completely dissolved purple crystal.ELIASA detects light absorbs, measure wavelength 490nm.Inhibiting rate=ABlank-ASample/ABlank×
100%, using ECCT concentration as abscissa, mapped by ordinate of inhibiting rate, calculate halves of the ECCT to different tumor cell lines
Inhibiting rate IC50Value.
As a result show, ECCT samples show stronger antitumor activity to 4 plants of tumour cells, to PC3, HepG2,
Colon38 and BGC823 IC50Value is respectively 18.27,61.61,10.92 and 14.37 μM.
Described above is only the preferred embodiment of the present invention, is not intended to limit the invention, it is noted that for this skill
For the those of ordinary skill in art field, without departing from the technical principles of the invention, can also make it is some improvement and
Modification, these improvement and modification also should be regarded as protection scope of the present invention.
Claims (9)
- A kind of 1. natural anti-infective antitumor bifunctional polypeptides ECCT, it is characterised in that:ECCT is by 30 amino acid residue groups Into straight-chain polypeptide, the Da of molecular weight 3662.7, isoelectric point 12.33, the primary structure of its amino acid sequence is SEQ ID NO.1 It is shown.
- 2. the encoding gene of the natural anti-infective antitumor bifunctional polypeptides ECCT described in claim 1, it is characterised in that:It is described Polypeptide ECCT precursor coding genes are made up of 720 nucleotides, and the base sequence from 5 ' ends to 3 ' ends is SEQ ID NO.2 institutes Show, and encode the ECCT 469-558 positions nucleotides for the SEQ ID NO.2 sequences.
- 3. natural anti-infective antitumor bifunctional polypeptides ECCT preparation method described in claim 1, it is characterised in that:By following Step is carried out successively:1)Extract the total serum IgE of water snake lung tissue;2)Construction cDNA library;3)Synthetic pcr primer thing is designed, enters performing PCR and expands to obtain ECCT coding gene sequence;4)Ripe peptide amino acid sequence is derived according to the ECCT coding gene sequences of PCR amplification gained;5)With automatic Peptide synthesizer synthesis polypeptide ECCT complete sequence;6)Pass through HPLC reversed phase column chromatography desalinations.
- 4. natural anti-infective antitumor bifunctional polypeptides ECCT preparation method according to claim 3, it is characterised in that:Step Rapid 3)Middle PCR primer includes forward primer SEQ ID NO:3 and reverse primer SEQ ID NO:4.
- 5. natural anti-infective antitumor bifunctional polypeptides ECCT application described in claim 1, it is characterised in that:It is antibacterial preparing Anti-inflammatory drugs, antineoplastic, preservative, animal feed and cosmetic caused by medicine, germ killing drugs, anti-helicobacter pylori LPS Application in product additive.
- 6. application according to claim 5, it is characterised in that:Suppress gram-positive bacterium, Gram-negative preparing Application in the medicine of bacterium and fungi
- 7. application according to claim 5, it is characterised in that:Suppress Escherichia coli, shigella dysenteriae, kerekou pneumonia preparing Primary bacterium, Klebsiella oxytoca, proteus mirabilis, stenotrophomonas maltophilia, pseudomonas aeruginosa, paratyphoid A Salmonella Bacterium, staphylococcus aureus, bacillus cereus, bacillus subtilis, VREF, Nocardia asteroides, Candida albicans and Application in the medicine of Candida glabrata.
- 8. application according to claim 5, it is characterised in that:Prepare anti-prostate cancer tumour medicine, anti-liver cancer and anti-tumour medicine Application in thing, inhibitor against colon carcinoma cells tumour medicine and anti-gastric cancer tumour medicine.
- 9. the application of natural anti-infective antitumor bifunctional polypeptides ECCT encoding gene according to claim 2, its feature It is:It is thin that the base sequence of the polypeptide ECCT is applied to polypeptide recombination expression, transgenic animals, plant, plant part, animal In born of the same parents or plant cell.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510341844.7A CN104987377B (en) | 2015-06-19 | 2015-06-19 | Natural anti-infective antitumor bifunctional polypeptides ECCT and its gene and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510341844.7A CN104987377B (en) | 2015-06-19 | 2015-06-19 | Natural anti-infective antitumor bifunctional polypeptides ECCT and its gene and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104987377A CN104987377A (en) | 2015-10-21 |
CN104987377B true CN104987377B (en) | 2018-03-06 |
Family
ID=54299292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510341844.7A Active CN104987377B (en) | 2015-06-19 | 2015-06-19 | Natural anti-infective antitumor bifunctional polypeptides ECCT and its gene and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104987377B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452856B2 (en) * | 2004-07-06 | 2008-11-18 | Seikagaku Corporation | Antibacterial peptide |
CN101412753A (en) * | 2008-09-27 | 2009-04-22 | 中国科学院昆明动物研究所 | Bungarus fasciatus antibacterial peptide cathelicidin-BF, and genes and uses thereof |
CN102652830B (en) * | 2012-05-04 | 2013-08-14 | 苏州康尔生物医药有限公司 | Application of Cathelicidin-BF (bungarus fasciatus) in preparation of antineoplastic medicament |
CN104497119B (en) * | 2013-12-09 | 2017-11-03 | 王义鹏 | A kind of natural antibacterial peptide and its application |
-
2015
- 2015-06-19 CN CN201510341844.7A patent/CN104987377B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104987377A (en) | 2015-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104497119B (en) | A kind of natural antibacterial peptide and its application | |
CN109837306A (en) | Contain the excretion body and its preparation method and application of miRNA-204-5p | |
CN101412753A (en) | Bungarus fasciatus antibacterial peptide cathelicidin-BF, and genes and uses thereof | |
CN114853865B (en) | Modified antibacterial peptide dsNCM1 and application thereof | |
CN104031135B (en) | Rhacophorus defense peptides PopuDef and gene thereof and application | |
CN110156875A (en) | Antibacterial peptide H5-p5 and its preparation method and application | |
CN104987377B (en) | Natural anti-infective antitumor bifunctional polypeptides ECCT and its gene and application | |
CN104530209B (en) | Bufo gargarizans Cantor cecropin B gene G CATH37, BG CATH (5 37) and its encoding gene and application | |
CN115043925B (en) | Modified antibacterial peptide oNCM and application thereof | |
CN110950947A (en) | Rana temporaria chensinensis host defense peptide DMS-PS2, and gene and application thereof | |
Zhuang et al. | Characterization of antibacterial activities and the related mechanisms of a β-defensin in turbot (Scophthalmus maximus) | |
CN104945494B (en) | A kind of Sinonatrix annularis source antibacterial polypeptide SAC and application | |
CN104910266A (en) | Amolops wuyiensis antibacterial peptide as well as encoding gene and application thereof | |
CN106432483B (en) | Rana chensinensis skin serine protease inhibitory peptide, gene and pharmaceutical application thereof | |
CN113527461B (en) | Horseshoe head bats source antibacterial peptide RF-CATH1 and application thereof | |
KR20200144835A (en) | Novel peptide from Apis mellifera having antimicrobial activity and uses thereof | |
CN102786583B (en) | Rana kunyuensis modified antibacterial peptides as well as preparation method and application of rana kunyuensis kunyuenin kunyuenin-3 | |
CN102816223B (en) | Brachymystax lenok Cathelicidin antimicrobial peptide CATH_BARLE, and gene, preparation and application thereof | |
CN101724632B (en) | Bullfrog skin active peptide, gene and application thereof in pharmacy | |
CN102796176B (en) | Kunyuenin, preparation method and application | |
Anchana et al. | Green synthesis of garlic oil-mediated selenium nanoparticles and its antimicrobial and cytotoxic activity. | |
CN107098963B (en) | Short peptide for inhibiting tumor and coding gene and application thereof | |
CN106146641B (en) | Rana limnocharis source cathelicidin family antibacterial peptide and its application | |
KR20220037035A (en) | Antibacterial peptide derived from Haliotis madaka | |
CN111518189A (en) | Antimicrobial peptide MSPiscidin-3, and coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |